HKSE - Delayed Quote HKD

CKLIFE SCIENCES (0775.HK)

0.520

+0.025

+(5.05%)

At close: January 28 at 12:08:04 PM GMT+8

Undervalued Small Caps With Insider Activity To Watch In January 2025

As we enter January 2025, global markets are grappling with a mix of economic signals, including a resilient U.S. labor market and ongoing inflation concerns that have sent small-cap stocks into correction territory, as evidenced by the Russell 2000 Index's recent dip. Amid this backdrop of uncertainty and fluctuating investor sentiment, identifying promising small-cap opportunities requires a keen eye on factors such as value resilience and insider activity, which can provide insights into...

Simply Wall St. 14 days ago

2368.HK

0775.HK
+5.05%
ARIS.MI
Undervalued Small Caps With Insider Buying To Explore In December 2024

As global markets navigate a complex landscape marked by interest rate cuts from the ECB and SNB, and expectations of a similar move by the Fed, small-cap stocks have faced challenges, with the Russell 2000 Index underperforming against larger indices like the S&P 500. Amidst this backdrop of fluctuating economic indicators and market sentiment, identifying promising small-cap stocks requires careful consideration of factors such as financial health, growth potential, and insider activity.

Simply Wall St. last month

0775.HK
+5.05%
NGCRF

NGCRY
Undervalued Small Caps With Insider Action Across Regions In November 2024

Global markets have recently experienced volatility, with U.S. stocks retracting some gains amid uncertainties surrounding the new administration's policies and their potential impact on corporate earnings. The S&P 600, a key index for small-cap stocks, reflects this broader market sentiment as investors navigate through economic indicators such as inflation data and interest rate expectations. In this context, identifying promising small-cap opportunities often involves looking at companies...

Simply Wall St. 2 months ago

2148.HK

0775.HK
+5.05%
KALAMANDIR.BO
Virios Therapeutics Enters Into Definitive Merger Agreement With Wex Pharmaceuticals

Virios Therapeutics Enters Into Definitive Merger Agreement With Wex Pharmaceuticals

PREMIUM
MT Newswires 3 months ago

VIRI

^YH206

Performance Overview

Return	0775.HK	HANG SENG INDEX
YTD	+28.40%	+0.92%
1-Year	-10.34%	+26.79%
3-Year	-25.91%	-15.05%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

CKLIFE SCIENCES (0775.HK)

Undervalued Small Caps With Insider Activity To Watch In January 2025

Undervalued Small Caps With Insider Buying To Explore In December 2024

Undervalued Small Caps With Insider Action Across Regions In November 2024

Virios Therapeutics Enters Into Definitive Merger Agreement With Wex Pharmaceuticals

Performance Overview